CDH Investments Backs Chinese Biotech Start-Up In $23M Series A Round

Chinese biotechnology start-up GemPharmatech has raised RMB160 million (US$23.24 million) in a series A round of financing from investors including the country’s alternative asset management firm CDH Investments, according to a company statement.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

LEAVE A REPLY